▁Vienna 10.375
, 5.38671875
▁Austria 5.796875
▁- 6.1484375
▁In 6.30859375
▁a 4.52734375
▁significant 8.609375
▁mil 6.3671875
estone 1.26953125
▁for 3.60546875
▁the 1.7353515625
▁British 6.9921875
▁bi 9.0859375
ote 3.931640625
ch 0.91845703125
▁sector 4.640625
, 1.53515625
▁the 2.0
▁revolution 7.48828125
ary 1.0458984375
▁anti 6.76953125
- 0.62255859375
can 4.4375
cer 0.04986572265625
▁treatment 4.55078125
▁Mar 11.8046875
im 8.625
ast 10.6171875
at 2.62109375
, 2.162109375
▁developed 8.9296875
▁by 1.0634765625
▁a 3.072265625
▁cutting 7.12890625
- 0.63037109375
edge 0.08837890625
▁UK 7.55078125
▁bi 2.486328125
ote 0.01263427734375
ch 0.1556396484375
▁firm 4.65234375
, 1.0234375
▁is 4.0859375
▁set 5.01171875
▁to 0.413818359375
▁under 5.953125
go 0.0943603515625
▁a 1.09375
▁compreh 4.9453125
ensive 0.09295654296875
▁review 4.2734375
▁at 4.59765625
▁the 0.82958984375
▁up 6.11328125
coming 0.96533203125
▁European 6.90234375
▁Society 6.6796875
▁for 2.25390625
▁Medical 4.92578125
▁On 4.29296875
col 0.140625
ogy 0.137939453125
▁( 3.091796875
ES 1.7890625
MO 0.15771484375
) 1.0751953125
▁conference 3.744140625
▁in 1.8427734375
▁Vienna 2.9609375
. 2.00390625
<0x0A> 0.931640625
Mar 5.203125
im 0.38427734375
ast 0.5888671875
at 0.021575927734375
▁is 1.6123046875
▁a 0.87451171875
▁prom 4.64453125
ising 0.0023956298828125
▁drug 3.36328125
▁designed 5.14453125
▁to 0.3310546875
▁combat 2.798828125
▁cancer 2.482421875
▁by 2.541015625
▁target 2.099609375
ing 0.0099639892578125
▁and 3.076171875
▁in 2.142578125
hib 0.07073974609375
iting 0.0108642578125
▁the 0.87060546875
▁growth 2.41015625
▁of 0.2216796875
▁tum 2.248046875
ors 1.6630859375
. 1.0068359375
▁This 2.736328125
▁ground 5.3125
bre 0.375244140625
aking 0.001171112060546875
▁treatment 2.716796875
▁has 2.1796875
▁spark 7.81640625
ed 0.0025234222412109375
▁w 4.62109375
ides 0.0011243820190429688
p 0.0006532669067382812
read 0.000118255615234375
▁excitement 2.306640625
▁within 3.30078125
▁the 0.099853515625
▁medical 0.9580078125
▁community 0.421142578125
▁due 3.421875
▁to 0.01184844970703125
▁its 0.33154296875
▁potential 2.419921875
▁for 2.216796875
▁significant 4.90234375
▁improvements 2.720703125
▁in 0.34375
▁cancer 1.80859375
▁ther 3.0
apy 0.1861572265625
▁out 4.7421875
comes 0.00911712646484375
. 0.433349609375
<0x0A> 0.5908203125
The 1.841796875
▁ES 3.92578125
MO 0.01201629638671875
▁conference 0.72802734375
, 2.048828125
▁one 5.09375
▁of 0.00433349609375
▁Europe 3.09375
' 0.00675201416015625
s 0.0008225440979003906
▁most 1.373046875
▁pr 0.8330078125
estig 2.276897430419922e-05
ious 0.00013399124145507812
▁gather 4.24609375
ings 0.0196533203125
▁in 2.333984375
▁the 0.173095703125
▁field 1.2939453125
▁of 0.06488037109375
▁medical 1.24609375
▁on 0.2169189453125
col 0.0003528594970703125
ogy 2.4437904357910156e-05
, 0.1025390625
▁will 0.94873046875
▁provide 3.19921875
▁a 1.1728515625
▁platform 1.1162109375
▁for 0.12005615234375
▁exper 3.138671875
ts 0.00031876564025878906
▁to 1.154296875
▁scr 7.91015625
ut 0.00014889240264892578
in 0.0002639293670654297
ize 0.03875732421875
▁the 0.8740234375
▁scientific 3.96484375
▁adv 2.625
anc 0.51416015625
ements 2.396106719970703e-05
▁and 1.5986328125
▁effic 5.24609375
acy 0.01059722900390625
▁of 0.148681640625
▁Mar 0.8701171875
im 0.0012655258178710938
ast 0.0092926025390625
at 0.0017757415771484375
. 1.2373046875
▁This 2.318359375
▁review 4.71875
▁a 3.46484375
ims 0.0016603469848632812
▁to 0.027679443359375
▁evaluate 4.03515625
▁the 0.42431640625
▁treatment 3.32421875
' 0.353515625
s 0.00030684471130371094
▁safety 3.1953125
▁profile 2.861328125
, 0.7333984375
▁its 2.890625
▁potential 2.6015625
▁side 2.689453125
▁effects 0.092041015625
, 0.1708984375
▁and 0.4248046875
▁most 6.37890625
▁important 0.314697265625
ly 0.007076263427734375
, 0.42919921875
▁its 0.4267578125
▁effect 1.771484375
iveness 0.02716064453125
▁in 0.5380859375
▁comb 2.1171875
ating 0.309326171875
▁various 2.470703125
▁types 0.603515625
▁of 0.016571044921875
▁cancer 0.27880859375
. 0.28564453125
<0x0A> 0.2017822265625
Develop 6.61328125
ed 0.427001953125
▁by 0.2919921875
▁the 1.5068359375
▁dedicated 9.5234375
▁team 1.14453125
▁at 0.36181640625
▁the 1.3994140625
▁British 3.939453125
▁bi 0.2056884765625
ote 0.00029087066650390625
ch 0.06634521484375
▁firm 0.2435302734375
, 0.87158203125
▁the 2.587890625
▁treatment 2.76171875
' 2.7890625
s 0.0011701583862304688
▁mechanism 4.06640625
▁is 3.642578125
▁centered 3.94140625
▁around 1.29296875
▁its 1.8515625
▁ability 1.0849609375
▁to 0.0020656585693359375
▁in 1.4638671875
hib 0.0108489990234375
it 0.0016736984252929688
▁a 3.53125
▁group 4.58203125
▁of 0.005359649658203125
▁en 0.91796875
zym 0.0001894235610961914
es 0.00830841064453125
▁known 0.9189453125
▁as 0.026611328125
▁matrix 6.234375
▁metal 0.01849365234375
lo 0.0014581680297851562
prote 0.01947021484375
in 0.102783203125
ases 0.1278076171875
▁( 0.4306640625
M 0.04876708984375
MP 0.00464630126953125
s 0.256591796875
). 0.3916015625
▁These 1.0166015625
▁en 0.329833984375
zym 5.030632019042969e-05
es 0.0017566680908203125
▁play 1.7763671875
▁a 0.371337890625
▁cru 1.6064453125
cial 0.0005078315734863281
▁role 0.032073974609375
▁in 0.0273284912109375
▁the 0.57470703125
▁pro 3.2578125
gression 0.1292724609375
▁and 1.5380859375
▁spread 1.125
▁of 0.0936279296875
▁tum 1.845703125
ors 0.16943359375
▁and 3.044921875
▁cancer 3.41796875
ous 1.1748046875
▁cells 0.388916015625
. 0.64599609375
▁By 1.9140625
▁hal 5.51171875
ting 0.0005702972412109375
▁their 1.005859375
▁activity 1.119140625
, 0.1068115234375
▁Mar 0.369384765625
im 0.0012359619140625
ast 0.0032939910888671875
at 0.0010824203491210938
▁a 2.03125
ims 0.0271453857421875
▁to 0.0035457611083984375
▁imp 5.08203125
ede 0.0933837890625
▁the 0.74462890625
▁ag 6.8046875
gress 0.053253173828125
ive 0.1407470703125
▁growth 0.466552734375
▁and 1.5048828125
▁expansion 4.02734375
▁of 0.036407470703125
▁cancer 0.92626953125
, 4.86328125
▁potentially 3.970703125
▁offering 3.046875
▁a 1.5673828125
▁new 2.1796875
▁weapon 5.65625
▁in 0.55322265625
▁the 0.128662109375
▁fight 0.62890625
▁against 0.0149688720703125
▁this 1.9736328125
▁dev 2.275390625
ast 0.0003390312194824219
ating 0.0008902549743652344
▁disease 0.1287841796875
. 0.0167083740234375
<0x0A> 0.038970947265625
E 4.625
ar 1.2900390625
ly 0.48046875
▁pre 4.79296875
cl 0.58203125
in 1.8715858459472656e-05
ical 0.0005240440368652344
▁tri 1.8466796875
als 0.00016260147094726562
▁have 0.82275390625
▁demonstrated 1.646484375
▁prom 2.365234375
ising 0.00012004375457763672
▁results 0.258544921875
, 1.3349609375
▁showing 3.1015625
▁Mar 3.943359375
im 0.0011539459228515625
ast 0.002864837646484375
at 0.0022487640380859375
' 0.52587890625
s 0.0005860328674316406
▁ability 1.17578125
▁to 0.002765655517578125
▁effectively 2.275390625
▁suppress 3.765625
▁tum 1.50390625
or 0.2471923828125
▁growth 0.2822265625
▁in 1.4560546875
▁various 2.87890625
▁types 0.97021484375
▁of 0.006988525390625
▁cancer 0.19091796875
, 1.892578125
▁including 0.441650390625
▁breast 1.30859375
▁and 2.671875
▁col 3.98046875
ore 0.0057220458984375
ct 0.0001055002212524414
al 0.0005240440368652344
▁cancer 0.958984375
. 0.19482421875
▁Such 6.74609375
▁positive 3.138671875
▁out 1.6640625
comes 0.0014066696166992188
▁have 0.50927734375
▁generated 4.4140625
▁significant 2.05859375
▁anticip 4.6328125
ation 0.0084991455078125
, 3.646484375
▁leading 2.662109375
▁research 4.0859375
ers 0.041107177734375
▁and 1.47265625
▁health 3.79296875
care 0.306396484375
▁profession 0.4521484375
als 1.6927719116210938e-05
▁to 0.1497802734375
▁eager 2.376953125
ly 0.00013625621795654297
▁await 0.8720703125
▁the 0.42431640625
▁outcome 4.26953125
▁of 0.018035888671875
▁the 0.763671875
▁rig 6.41015625
orous 0.017730712890625
▁evaluation 4.06640625
▁at 2.77734375
▁the 0.222900390625
▁ES 0.5419921875
MO 0.0007042884826660156
▁conference 0.10589599609375
. 0.1859130859375
<0x0A> 0.06475830078125
Dr 5.8046875
. 0.1083984375
▁Cla 5.80859375
ire 0.61376953125
▁Hamilton 6.609375
, 0.24072265625
▁the 1.9052734375
▁lead 2.47265625
▁research 0.89501953125
er 0.01056671142578125
▁behind 2.54296875
▁Mar 2.130859375
im 0.0007524490356445312
ast 0.0018529891967773438
at 0.002685546875
' 1.1865234375
s 0.0009608268737792969
▁development 0.74072265625
, 0.25048828125
▁expressed 3.51171875
▁her 0.4228515625
▁excitement 0.391845703125
▁about 2.09375
▁the 0.14501953125
▁treatment 2.34375
' 0.0784912109375
s 0.00023365020751953125
▁up 2.962890625
coming 0.0006275177001953125
▁review 1.3662109375
, 2.4921875
▁stating 0.9267578125
, 0.96826171875
▁" 0.07470703125
Mar 2.294921875
im 0.0006127357482910156
ast 0.0017404556274414062
at 0.0005259513854980469
▁represents 3.2421875
▁a 0.37548828125
▁ground 3.20703125
bre 0.1309814453125
aking 0.0001271963119506836
▁approach 2.677734375
▁to 0.32421875
▁cancer 1.38671875
▁treatment 0.5595703125
. 1.4287109375
▁The 2.154296875
▁ES 4.05078125
MO 0.0014352798461914062
▁review 3.173828125
▁is 1.73046875
▁an 1.04296875
▁un 4.83203125
par 1.1669921875
alle 0.0015325546264648438
led 1.0013580322265625e-05
▁opportunity 0.11212158203125
▁for 1.134765625
▁expert 6.3828125
▁evaluation 2.76953125
, 1.7470703125
▁opening 6.5859375
▁the 0.64453125
▁door 0.2259521484375
▁for 1.5126953125
▁potential 3.33203125
▁world 6.71875
wide 0.2181396484375
▁accept 2.90234375
ance 0.0015172958374023438
▁and 1.4375
▁w 2.62109375
ides 0.0002110004425048828
p 0.001247406005859375
read 0.0002129077911376953
▁use 1.3857421875
▁of 0.77783203125
▁this 0.47021484375
▁novel 3.0859375
▁th 3.642578125
era 3.5881996154785156e-05
pe 3.1828880310058594e-05
ut 2.3126602172851562e-05
ic 0.0038604736328125
▁option 1.9140625
." 0.498046875
<0x0A> 0.06854248046875
The 1.8369140625
▁conference 4.02734375
▁is 1.5732421875
▁expected 1.6484375
▁to 0.0010356903076171875
▁attract 3.005859375
▁prominent 4.42578125
▁on 3.5234375
colog 0.493896484375
ists 0.024444580078125
, 0.61279296875
▁medical 1.7939453125
▁research 1.3466796875
ers 0.0252685546875
, 0.056488037109375
▁and 0.228515625
▁industry 3.041015625
▁exper 1.3642578125
ts 7.867813110351562e-06
▁from 0.59521484375
▁around 0.916015625
▁the 0.00980377197265625
▁glo 1.1494140625
be 0.00028443336486816406
. 0.6806640625
▁The 2.0546875
▁critical 8.234375
▁analysis 2.69921875
▁and 1.953125
▁strateg 6.77734375
ic 0.052520751953125
▁discussion 2.541015625
▁of 1.7919921875
▁Mar 0.47314453125
im 0.0002543926239013672
ast 0.00232696533203125
at 0.0007739067077636719
' 0.66064453125
s 0.0006117820739746094
▁effic 1.6044921875
acy 3.337860107421875e-05
▁will 1.7314453125
▁fuel 7.75390625
▁further 2.142578125
▁ins 6.41796875
ights 0.00128936767578125
▁into 0.68310546875
▁the 0.73291015625
▁potential 2.212890625
▁value 5.35546875
▁it 3.017578125
▁may 1.841796875
▁bring 2.20703125
▁to 0.28857421875
▁the 0.75927734375
▁field 2.548828125
▁of 0.293212890625
▁cancer 1.6103515625
▁ther 1.646484375
apy 0.005313873291015625
. 0.2027587890625
<0x0A> 0.36279296875
Wh 5.33203125
ile 0.12359619140625
▁Mar 2.0390625
im 0.0004172325134277344
ast 0.0017137527465820312
at 0.0005602836608886719
▁still 4.8046875
▁has 0.78466796875
▁a 0.56689453125
▁long 0.2130126953125
▁journey 3.34375
▁before 3.72265625
▁it 0.49560546875
▁can 1.5751953125
▁be 0.83251953125
▁made 2.4921875
▁available 0.228759765625
▁to 0.2587890625
▁patients 0.98876953125
, 0.30859375
▁the 0.83203125
▁ES 2.380859375
MO 0.00020587444305419922
▁review 1.966796875
▁is 1.4775390625
▁a 1.1826171875
▁significant 1.4345703125
▁step 1.1337890625
▁towards 1.3115234375
▁gain 4.6796875
ing 0.0005259513854980469
▁regul 2.28125
atory 0.00106048583984375
▁appro 0.0731201171875
val 2.753734588623047e-05
▁and 1.15625
▁progress 7.5859375
ing 0.125
▁towards 1.53125
▁clin 3.1796875
ical 0.00637054443359375
▁tri 0.802734375
als 0.0001888275146484375
. 0.247802734375
▁If 4.92578125
▁successful 1.1826171875
, 0.0428466796875
▁this 1.423828125
▁anti 7.78125
- 0.002529144287109375
can 0.08648681640625
cer 0.00025272369384765625
▁break 6.93359375
through 0.0002944469451904297
▁could 0.65673828125
▁revolution 2.15625
ize 0.009521484375
▁treatment 3.01953125
▁options 1.16796875
▁and 1.8603515625
▁provide 2.59765625
▁renew 7.5234375
ed 0.00027632713317871094
▁hope 0.01373291015625
▁for 0.65234375
▁count 3.587890625
less 1.1205673217773438e-05
▁individuals 2.724609375
▁affected 2.302734375
▁by 0.003253936767578125
▁cancer 1.2041015625
▁world 3.2421875
wide 0.0010404586791992188
. 0.00753021240234375
<0x0A> 0.139892578125
As 4.94140625
▁anticip 7.1953125
ation 0.280517578125
▁mount 2.669921875
s 0.0001461505889892578
, 1.8583984375
▁the 1.09765625
▁global 3.802734375
▁medical 0.744140625
▁community 0.055389404296875
▁eager 3.65625
ly 0.00019943714141845703
▁a 0.036163330078125
wa 9.417533874511719e-06
its 7.3909759521484375e-06
▁the 0.22412109375
▁out 3.69921875
comes 0.00563812255859375
▁of 0.1099853515625
▁the 0.2822265625
▁compreh 6.015625
ensive 0.0004246234893798828
▁review 0.69921875
▁at 0.51904296875
▁the 0.1033935546875
▁ES 0.4677734375
MO 0.0002689361572265625
▁conference 0.041748046875
, 2.017578125
▁recogn 7.6484375
izing 0.00547027587890625
▁that 3.5
▁it 3.15234375
▁could 1.171875
▁shape 4.0703125
▁the 0.09100341796875
▁future 0.164306640625
▁of 0.040191650390625
▁cancer 0.52880859375
▁treatment 0.69921875
▁practices 7.87109375
. 1.0888671875
